rss feeds Last update US appeals court upholds delay in Alzheimer's drug swap, May 22, 2015

Medications news

DUR-928 compound continues phase 1 clinical trials

A therapeutic compound developed at Virginia Commonwealth University, which may have broad applicability in acute organ injuries and in several metabolic diseases such as nonalcoholic fatty liver disease and nonalcoholic ...

May 19, 2015
popularity 18 comments 0

More News Stories

Spinal stimulation system relieves pain without tingling

(HealthDay)—The Senza spinal cord stimulation system has been approved by the U.S. Food and Drug Administration to treat chronic back pain without the tingling sensation that characterizes more traditional pain-relieving ...

Avelox approved for plague

(HealthDay)—Avelox (moxifloxacin) was approved by the U.S. Food and Drug Administration on Friday to treat plague, a rare but deadly bacterial infection that can strike the lungs (pneumonic), blood (septicemic) or lymph ...

How World War II spurred vaccine innovation

War and disease have marched arm in arm for centuries. Wars magnify the spread and severity of disease by disrupting populations. As large groups of people move across borders, they introduce and encounter ...

Other Spotlight Stories

Find more Medications news articles via sort by date page